Tumor-antigen heterogeneity of disseminated breast cancer cells: Implications for immunotherapy of minimal residual disease

International Journal of Cancer

Volumn 84, Issue 1, 1999, Pages 1-5

  Braun, Stephan ^a   Hepp, Florian ^a   Sommer, Harald L ^a   Pantel, Klaus ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EDRECOLOMAB; LE(Y) ANTIGEN; MEMBRANE ANTIGEN; ONCOPROTEIN; TUMOR ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW PURGING; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

EID: 0032962333     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990219)84:1<1::AID-IJC1>3.0.CO;2-A     Document Type: Article

References (30)

1. ALLGAYER, H., HEISS, M.M., RIESENBERG, R., GRUETZNER, K.U., TARABICHI, A., BABIC, R. and SCHILDBERG, F.W., Urokinase plasminogen activator receptor (uPA-R): one potential characteristic of metastatic phenotypes in minimal residual tumor disease. Cancer Res., 57, 1394-1399 (1997).
2. BASELGA, J. and 12 OTHERS, Phase II study of weekly intravenous recombinant humanized anti-p185Her2 monoclonal antibody in patients with Her2/neu-overexpressing metastatic breast cancer. J. clin. Oncol., 14, 737-744 (1996).
3. BRAUN, S., MÜLLER, M., HEPP, F., SCHLIMOK, G., RIETHMÜLLER, G. and PANTEL, K., Re: Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J. nat. Cancer Inst. (1998). (In press).
4. BRAUN, S. and PANTEL, K., Biological characteristics of micrometastatic carcinoma cells in bone marrow. In: U. Günthert and W. Birchmeier (eds.). Attempts to understand metastasis formation. Current Topics in Microbiology and Immunology, vol. 213/1, pp. 163-177. Springer, New York (1996).
5. BRONCKERS, A.L.J.J., GAY, S., FINKELMAN, R.D. and BUTLER, W.T., Immunolocalization of Gla proteins (osteocalcin) in rat tooth germs: comparison between indirect immunfluorescence, peroxidase-antiperoxidase, avidin-biotin complex, and avidin-biotin-gold complex with silver enhancement. J. Histochem. Cytochem., 35, 825-830 (1987).
6. CORDELL, J.L., FALINI, B., ERBER, W.N., GHOSH, A.K., ABDULAZIZ, Z., MACDONALD, S., PULFORD, K.A.F., STEIN, H. and MASON, D.Y., Immuno-enzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP-complexes). J. Histochem. Cytochem., 32, 219-229 (1984).
7. DE WAELE, M., RENMANS, W., SEGERS, E., JOCHMANS, K. and VAN CAMP, B., Sensitive detection of immunogold-silver staining with darkfield and epi-polarization microscopy. J. Histochem. Cytochem., 36, 679-683 (1988).
8. DIEL, I.J., KAUEMANN, M., COSTA, S.D., HOLLE, R., VON MINCKWITZ, G., SOLOMAYERR, E.F., KAUL, S. and BASTERT, G., Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J. nat. Cancer Inst., 88, 1652-1664 (1996).
9. DILLMAN, R.O., Antibodies as cytotoxic therapy. J. clin. Oncol., 12, 1497-1515 (1994).
10. FIDLER, I.J., Modulation of the organ environment for treatment of cancer metastases. J. nat. Cancer Inst., 87, 1588-1592 (1995).
11. FUNKE, I., FRIES, S., ROLLE, M., HEISS, M.M., UNTCH, M., BOHMERT, H., SCHILDBERG, F.W. and JAUCH, K.W., Comparative analyses of bone marrow micrometastases in breast and gastric cancer. Int. J. Cancer, 65, 755-761 (1996).
12. GÖTTLINGER, H.G., FUNKE, I., JOHNSON, J.P., GOKEL, J.M. and RIETHMÜLLER, G., The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies. Int. J. Cancer, 38, 47-53 (1986).
13. HÄMMERLING, G., MASCHEK, V., STURMHÖFEL, K. and MOMBURG, F., Regulation and functional role of MHC expression on tumors. In: F. Melchers (ed.), Progress in Immunology, pp. 1071-1078, Springer, Berlin (1989).
14. HARRISON, W.J., The total cellularity of the bone marrow in man. J. clin. Pathol., 15, 254-259 (1962).
15. HEISS, M.M., ALLGAYER, H., GRUETZNER, K.U., FUNKE, I., BABIC, R., JAUCH, K.W. and SCHILDBERG, F.W., Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancer. Nature (Med.), 1, 1035-1039 (1995).
16. JAIN, R.K., Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. Cancer Res., 50, 2741-2451 (1990).
17. NAUME, B., BORGEN, E., BEISKE, K., HERSTAD, T.K., RAVNÅS, G., RENOLEN, A., TRACHSEL, S., THARNE-STEEN, K., FUNDERUD, S. and KVALHEIM, G., Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood. J. Hematother., 6, 103-114 (1997).
18. PANTEL, K., SCHLIMOK, G., ANGSTWURM, M., WECKERMANN, C., SCHMAUS, W., GATH, H., PASSLICK, B., IZBICKI, J. and RIETHMÜLLER, G., Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J. Hematother., 3, 165-173 (1994).
19. PANTEL, K., SCHLIMOK, G., BRAUN, S., KUTTER, D., SCHALLER, G., FUNKE, I., IZBICKI, J. and RIETHMÜLLER, G., Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J. nat. Cancer Inst., 85, 1419-1424 (1993).
20. PANTEL, K., SCHLIMOK, G., KUTTER, D., SCHALLER, G., GENZ, T., WIEBECKE, B., BACKMANN, R., FUNKE, I. and RIETHMÜLLER, G., Frequent down-regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells. Cancer Res., 51, 4712-4715 (1991).
21. RIESENBERG, R., OBERNEDER, R., KRIEGMAIR, M., EPP, M., BITZER, U., HOESTETTER, A., BRAUN, S., RIETHMÜLLER, G. and PANTEL, K., Immunocytochemical double staining of cytokeratin and prostate specific antigen in individual prostatic tumor cells. Histochemistry, 99, 61-66 (1993).
22. RIETHMÜLLER, G. and JOHNSON, J.P., Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancer. Curr. Opin. Immunol., 4, 647-655 (1992).
23. REITHMÜLLER, G., SCHNEIDER-GÄDICKE, E., SCHLIMOK, G., SCHMIEGEL, W., RAAB, R., HÖFFKEN, K., GRUBER, R., PICHLMAIER, H., HIRCHE, H., PICHLMAYR, R., BUGGISCH, P., WITTE, J. and THE GERMAN CANCER AID 17-1A STUDY GROUP. Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes C colorectal carcinoma. Lancet, 343, 1177-1183 (1994).
24. SCHLIMOK, G., FUNKE, I., PANTEL, K., STROBEL, F., LINDEMANN, F., WITTE, J. and RIETHMÜLLER, G., Micrometastatic tumor cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Europ. J. Cancer, 27, 1461-1465 (1991).
25. SCOTT, A.M. and WELT, S., Antibody-based immunological therapies. Curr. Opin. Immunol., 9, 717-722 (1997).
26. SIKUT, R., ZHANG, K., BAECKSTROEM, D. and HANSSON, G.C., Distinct sub-populations of carcinoma-associated MUC1 mucins as detected by monoclonal antibody 9H8 and antibodies against the sialyl-Lewis a and sialyl-Lewis x epitopes in the circulation of breast cancer patients. Int. J. Cancer, 66, 6117-6123 (1996).
27. SLAMON, J.D., GODOLPHIN, W., JONES, L.A., HOLT, J.A., WONG, S.G., KEITH, D.E., LEVIN, W.J., STUART, S.G., UDOVE, J., ULLRICH, A. and PRESS, M.F., Studies of the HER-2/neu proto-oncogene in human breast cancer and ovarian cancer. Science, 244, 707-712 (1989).
28. STIGBRAND, T. and 22 OTHERS, Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: the ISOBM TD5-1 workshop. Tumor Biol., 19, 123-152 (1998).
29. TAYLOR-PAPADIMITRIOU, J., BURCHELL, J., MOSS, F. and BEVERLY, P., Monoclonal antibodies to epithelial membrane antigen and human milk fat globule mucin define epitopes expressed on other molecules. Lancet, 1, 458 (1985).
30. ZHANG, S., ZHANG, H.S., REUTER, V.E., SLOVIN, S.F., SCHER, H.I. and LIVINGSTON, P.O., Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancer. Clin. Cancer Res., 4, 295-302 (1998).